ASLAN Pharma Analyst Ratings
ASLAN Pharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/06/2023 | 1445.45% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
| 08/14/2023 | 1263.64% | Roth MKM | → $15 | Reiterates | Buy → Buy |
| 08/14/2023 | 1445.45% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
| 07/07/2023 | 1445.45% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
| 06/26/2023 | 1445.45% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
| 06/23/2023 | 1445.45% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
| 05/31/2023 | 1263.64% | Roth MKM | → $15 | Initiates Coverage On | → Buy |
| 04/28/2023 | 1445.45% | HC Wainwright & Co. | $20 → $17 | Maintains | Buy |
| 03/27/2023 | 1718.18% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 03/20/2023 | 1718.18% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 03/01/2023 | 309.09% | HC Wainwright & Co. | → $4.5 | Reiterates | → Buy |
| 02/27/2023 | 172.73% | Piper Sandler | $4 → $3 | Maintains | Overweight |
| 02/27/2023 | 309.09% | HC Wainwright & Co. | $7 → $4.5 | Maintains | Buy |
| 09/16/2022 | 263.64% | Piper Sandler | $3 → $4 | Maintains | Overweight |
| 08/15/2022 | 536.36% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 05/23/2022 | 172.73% | Piper Sandler | $8 → $3 | Maintains | Overweight |
| 07/09/2021 | 627.27% | Jefferies | → $8 | Initiates Coverage On | → Buy |
| 03/17/2021 | 627.27% | HC Wainwright & Co. | $5 → $8 | Maintains | Buy |
| 12/10/2019 | 354.55% | HC Wainwright & Co. | $2 → $5 | Reiterates | → Buy |
| 11/14/2019 | 81.82% | HC Wainwright & Co. | $9 → $2 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/06/2023 | 1445.45% | HC Wainwright & Co. | → 17 美元 | 重申 | 购买 → 购买 |
| 08/14/2023 | 1263.64% | Roth MKM | → 15 美元 | 重申 | 购买 → 购买 |
| 08/14/2023 | 1445.45% | HC Wainwright & Co. | → 17 美元 | 重申 | 购买 → 购买 |
| 07/07/2023 | 1445.45% | HC Wainwright & Co. | → 17 美元 | 重申 | 购买 → 购买 |
| 06/26/2023 | 1445.45% | HC Wainwright & Co. | → 17 美元 | 重申 | 购买 → 购买 |
| 06/23/2023 | 1445.45% | HC Wainwright & Co. | → 17 美元 | 重申 | 购买 → 购买 |
| 05/31/2023 | 1263.64% | Roth MKM | → 15 美元 | 启动覆盖范围开启 | → 购买 |
| 04/28/2023 | 1445.45% | HC Wainwright & Co. | 20 美元 → 17 美元 | 维护 | 买 |
| 03/27/2023 | 1718.18% | HC Wainwright & Co. | → 20 美元 | 重申 | → 购买 |
| 03/20/2023 | 1718.18% | HC Wainwright & Co. | → 20 美元 | 重申 | → 购买 |
| 03/01/2023 | 309.09% | HC Wainwright & Co. | → 4.5 美元 | 重申 | → 购买 |
| 02/27/2023 | 172.73% | 派珀·桑德勒 | 4 美元 → 3 美元 | 维护 | 超重 |
| 02/27/2023 | 309.09% | HC Wainwright & Co. | 7 美元 → 4.5 美元 | 维护 | 买 |
| 2022 年 9 月 16 日 | 263.64% | 派珀·桑德勒 | 3 美元 → 4 美元 | 维护 | 超重 |
| 08/15/2022 | 536.36% | HC Wainwright & Co. | 8 美元 → 7 美元 | 维护 | 买 |
| 05/23/2022 | 172.73% | 派珀·桑德勒 | 8 美元 → 3 美元 | 维护 | 超重 |
| 07/09/2021 | 627.27% | 杰富瑞集团 | → 8 美元 | 启动覆盖范围开启 | → 购买 |
| 03/17/2021 | 627.27% | HC Wainwright & Co. | 5 美元 → 8 美元 | 维护 | 买 |
| 2019 年 10 月 12 日 | 354.55% | HC Wainwright & Co. | 2 美元 → 5 美元 | 重申 | → 购买 |
| 2019 年 11 月 14 日 | 81.82% | HC Wainwright & Co. | 9 美元 → 2 美元 | 维护 | 买 |
What is the target price for ASLAN Pharma (ASLN)?
ASLAN Pharma (ASLN) 的目标价格是多少？
The latest price target for ASLAN Pharma (NASDAQ: ASLN) was reported by HC Wainwright & Co. on November 6, 2023. The analyst firm set a price target for $17.00 expecting ASLN to rise to within 12 months (a possible 1445.45% upside). 13 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月6日公布了亚斯兰制药（纳斯达克股票代码：ASLN）的最新目标股价。该分析公司将目标股价定为17.00美元，预计ASLN将在12个月内升至12个月内（可能上涨1445.45％）。去年有13家分析公司公布了评级。
What is the most recent analyst rating for ASLAN Pharma (ASLN)?
分析师对ASLAN Pharma（ASLN）的最新评级是多少？
The latest analyst rating for ASLAN Pharma (NASDAQ: ASLN) was provided by HC Wainwright & Co., and ASLAN Pharma reiterated their buy rating.
ASLAN Pharma（纳斯达克股票代码：ASLN）的最新分析师评级由HC Wainwright & Co. 提供，ASLAN Pharma 重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for ASLAN Pharma (ASLN)?
ASLAN Pharma（ASLN）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ASLAN Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ASLAN Pharma was filed on November 6, 2023 so you should expect the next rating to be made available sometime around November 6, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与ASLAN Pharma的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。ASLAN Pharma的最新评级是在2023年11月6日公布的，因此您应该预计下一个评级将在2024年11月6日左右公布。
Is the Analyst Rating ASLAN Pharma (ASLN) correct?
分析师对ASLAN Pharma (ASLN) 的评级是否正确？
While ratings are subjective and will change, the latest ASLAN Pharma (ASLN) rating was a reiterated with a price target of $0.00 to $17.00. The current price ASLAN Pharma (ASLN) is trading at is $1.10, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的ASLAN Pharma（ASLN）评级，目标股价为0.00美元至17.00美元。ASLAN Pharma（ASLN）目前的交易价格为1.10美元，在分析师的预测区间内。
译文内容由第三方软件翻译。